Front Barnett Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $10.2M | Sell |
130,170
-2,329
| -2% | -$195K | 1.22% | 27 |
|
|
2023
Q2 | $11.7M | Sell |
132,499
-1,482
| -1% | -$128K | 1.32% | 26 |
|
|
2023
Q1 | $10.8M | Sell |
133,981
-656
| -0.5% | -$53.5K | 1.27% | 27 |
|
|
2022
Q4 | $10.5M | Sell |
134,637
-3,040
| -2% | -$246K | 1.32% | 26 |
|
|
2022
Q3 | $11.1M | Buy |
137,677
+844
| +0.6% | +$75.8K | 1.47% | 27 |
|
|
2022
Q2 | $12.3M | Buy |
136,833
+870
| +0.6% | +$88.2K | 1.5% | 28 |
|
|
2022
Q1 | $15.1M | Buy |
135,963
+2,504
| +2% | +$265K | 1.52% | 26 |
|
|
2021
Q4 | $13.8M | Buy |
133,459
+2,009
| +2% | +$233K | 1.29% | 28 |
|
|
2021
Q3 | $16.5M | Sell |
131,450
-707
| -0.5% | -$91.5K | 1.69% | 25 |
|
|
2021
Q2 | $16.4M | Buy |
132,157
+1,018
| +0.8% | +$128K | 1.67% | 25 |
|
|
2021
Q1 | $15.5M | Buy |
131,139
+9,415
| +8% | +$1.1M | 1.72% | 25 |
|
|
2020
Q4 | $14.3M | Buy |
121,724
+3,845
| +3% | +$423K | 1.69% | 22 |
|
|
2020
Q3 | $12.3M | Buy |
117,879
+2,097
| +2% | +$211K | 1.67% | 20 |
|
|
2020
Q2 | $10.6M | Buy |
115,782
+816
| +0.7% | +$78.2K | 1.64% | 23 |
|
|
2020
Q1 | $10.4M | Buy |
114,966
+2,215
| +2% | +$236K | 1.98% | 16 |
|
|
2019
Q4 | $12.8M | Buy |
112,751
+898
| +0.8% | +$98.5K | 1.91% | 16 |
|
|
2019
Q3 | $12.1M | Buy |
111,853
+3,114
| +3% | +$325K | 2.01% | 17 |
|
|
2019
Q2 | $10.6M | Sell |
108,739
-320
| -0.3% | -$29.2K | 1.78% | 22 |
|
|
2019
Q1 | $9.93M | Sell |
109,059
-493
| -0.5% | -$44.1K | 1.6% | 23 |
|
|
2018
Q4 | $9.96M | Buy |
109,552
+2,959
| +3% | +$277K | 1.82% | 22 |
|
|
2018
Q3 | $10.5M | Buy |
106,593
+2,189
| +2% | +$202K | 1.58% | 24 |
|
|
2018
Q2 | $8.94M | Buy |
104,404
+412
| +0.4% | +$34.4K | 1.48% | 29 |
|
|
2018
Q1 | $8.34M | Buy |
103,992
+770
| +0.7% | +$63.5K | 1.4% | 31 |
|
|
2017
Q4 | $8.34M | Sell |
103,222
-1,682
| -2% | -$135K | 1.38% | 30 |
|
|
2017
Q3 | $8.16M | Buy |
104,904
+2,293
| +2% | +$190K | 1.43% | 30 |
|
|
2017
Q2 | $9.11M | Buy |
102,611
+29
| +0% | +$2.44K | 1.66% | 23 |
|
|
2017
Q1 | $8.26M | Sell |
102,582
-2,815
| -3% | -$220K | 1.54% | 25 |
|
|
2016
Q4 | $7.51M | Sell |
105,397
-4,095
| -4% | -$322K | 1.45% | 26 |
|
|
2016
Q3 | $9.46M | Buy |
109,492
+1,293
| +1% | +$113K | 1.81% | 19 |
|
|
2016
Q2 | $9.39M | Buy |
108,199
+782
| +0.7% | +$63.2K | 1.9% | 19 |
|
|
2016
Q1 | $8.06M | Buy |
107,417
+959
| +0.9% | +$72.2K | 1.62% | 23 |
|
|
2015
Q4 | $8.19M | Sell |
106,458
-64
| -0.1% | -$4.82K | 1.63% | 23 |
|
|
2015
Q3 | $7.13M | Buy |
106,522
+1,967
| +2% | +$145K | 1.48% | 25 |
|
|
2015
Q2 | $7.75M | Buy |
104,555
+1,680
| +2% | +$128K | 1.44% | 25 |
|
|
2015
Q1 | $8.02M | Buy |
+102,875
| New | +$7.8M | 1.48% | 24 |
|
Other funds holding MDT
Front Barnett Associates's MDT Position: Q3 2023 in Review
Front Barnett Associates reduced its Medtronic (MDT) stake by 1.8% in Q3 2023, selling an estimated $195K and leaving 130,170 shares worth $10.2M. The position accounts for 1.22% of the portfolio, ranked #27.
Front Barnett Associates first reported a position in MDT in Q1 2015 and has held it in 35 quarters since. The position peaked at $16.5M in Q3 2021. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.
- Front Barnett Associates held 130,170 shares of Medtronic worth $10.2M as of Q3 2023.
- Front Barnett Associates sold 2,329 Medtronic shares in Q3 2023, an estimated $195K.
- Medtronic made up 1.22% of Front Barnett Associates's portfolio in Q3 2023, its #27 holding.
- Front Barnett Associates first reported a position in Medtronic in Q1 2015 and has held it in 35 quarters since.
- Front Barnett Associates's Medtronic position peaked at $16.5M in Q3 2021.
- 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.
Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.